MedTrace Logo

Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's

NCT02507440 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-01-10

No results posted yet for this study

Summary

To find out if the administration of the local pharyngeal anesthetic, lidocaine, in conjunction with Propofol during elective Esophagogastroduodenoscopy (EGD) is useful, safe and impacts the time of discharge of patient compared to placebo.

Conditions

  • Topical Anesthesia

Interventions

DRUG

Lidocaine

Prior to initiation of anesthesia viscous lidocaine or placebo will be administered.

DRUG

Placebo

Prior to initiation of anesthesia viscous lidocaine or placebo will be administered.

DRUG

Propofol

All patients will receive intravenous propofol as anesthesia for EGD

Sponsors & Collaborators

  • Bassett Healthcare

    lead OTHER

Principal Investigators

  • david Ullman, MD · Bassett Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-10-31
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02507440 on ClinicalTrials.gov